Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bianca Maria Longo

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Antimicrobial Chemotherapy|August 16, 2024
Dual β-lactams for the treatment of Mycobacterium abscessus: a review of the evidence and a call to act against an antibiotic nightmareBianca Maria Longo, Mattia Trunfio, Andrea Calcagno
Journal of Global Antimicrobial Resistance|July 19, 2024
Risk factors for mortality in Acinetobacter baumannii bloodstream infections and development of a predictive mortality modelSilvia Corcione, Bianca Maria Longo, Silvia Scabini, et al.
Tropical Medicine & International Health : TM & IH|July 1, 2024
A noma case report: A warning message from Northern UgandaBianca Maria Longo, Martina Merli, Bonny Achana, et al.
Frontiers in Microbiology|April 5, 2021
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary CasesMattia Trunfio, Bianca Maria Longo, Francesca Alladio, et al.
Viruses|March 6, 2021
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic PatientsMattia Trunfio, Francesco Venuti, Francesca Alladio, et al.
Frontiers in Microbiology|August 25, 2025
Bloodstream infections epidemiology and clinical outcomes after 1 year post allogeneic hematogenous stem cell transplantationSilvia Corcione, Bianca Maria Longo, Walter Rugge, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infection in the Outpatient SettingFrancesco Venuti, Alberto Gaviraghi, Amedeo De Nicolò, et al.
Antibiotics (Basel, Switzerland)|September 28, 2023
Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case SeriesBianca Maria Longo, Francesco Venuti, Alberto Gaviraghi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Antimicrobial Chemotherapy|August 16, 2024
Dual β-lactams for the treatment of Mycobacterium abscessus: a review of the evidence and a call to act against an antibiotic nightmareBianca Maria Longo, Mattia Trunfio, Andrea Calcagno
Journal of Global Antimicrobial Resistance|July 19, 2024
Risk factors for mortality in Acinetobacter baumannii bloodstream infections and development of a predictive mortality modelSilvia Corcione, Bianca Maria Longo, Silvia Scabini, et al.
Tropical Medicine & International Health : TM & IH|July 1, 2024
A noma case report: A warning message from Northern UgandaBianca Maria Longo, Martina Merli, Bonny Achana, et al.
Frontiers in Microbiology|April 5, 2021
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary CasesMattia Trunfio, Bianca Maria Longo, Francesca Alladio, et al.
Viruses|March 6, 2021
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic PatientsMattia Trunfio, Francesco Venuti, Francesca Alladio, et al.
Frontiers in Microbiology|August 25, 2025
Bloodstream infections epidemiology and clinical outcomes after 1 year post allogeneic hematogenous stem cell transplantationSilvia Corcione, Bianca Maria Longo, Walter Rugge, et al.
Antibiotics (Basel, Switzerland)|July 29, 2023
Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant <i>Pseudomonas aeruginosa</i> Infection in the Outpatient SettingFrancesco Venuti, Alberto Gaviraghi, Amedeo De Nicolò, et al.
Antibiotics (Basel, Switzerland)|September 28, 2023
Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case SeriesBianca Maria Longo, Francesco Venuti, Alberto Gaviraghi, et al.
Pageof 1